| NCT00005188 |
|
Quantitative Genetic Analysis of Lipid Research Clinic Family Data
|
View
|
| NCT00005187 |
|
Cardiovascular Risk Profile Among Mexican-Americans
|
View
|
| NCT00005186 |
|
Epidemiology of Cardiovascular Diseases in The Elderly
|
View
|
| NCT00005185 |
|
Myocardial Infarction and Non-contraceptive Estrogen Use
|
View
|
| NCT00005184 |
|
Immunogenetic Factors of Coronary Heart Disease
|
View
|
| NCT00005183 |
|
Apolipoprotein A-I Gene Polymorphism and Atherosclerosis
|
View
|
| NCT00005182 |
|
Health Professionals Follow-up Study
|
View
|
| NCT00005181 |
|
Blood Pressure Control in Juveniles - Longitudinal Study
|
View
|
| NCT00005180 |
|
End-organ Pathology in Childhood Essential Hypertension
|
View
|
| NCT00005179 |
|
Diet Exercise and Cardiovascular Health Among Ethnic Children
|
View
|
| NCT00005178 |
|
Study of Childrens Activity and Nutrition SCAN
|
View
|
| NCT00005177 |
|
Reno Diet Heart Study
|
View
|
| NCT00005176 |
|
Long QT Syndrome-Population Genetics and Cardiac Studies
|
View
|
| NCT00005175 |
|
Coronary Heart Disease Risk Factors in Upwardly Mobile Blacks and Whites
|
View
|
| NCT00005174 |
|
Western Collaborative Group Study WCGS 25-Year Follow-up of Cardiovascular Disease Morbidity and Mortality
|
View
|
| NCT00005173 |
|
Myocardial Infarction and Past Oral Contraceptive Use
|
View
|
| NCT00005172 |
|
Socioeconomic Status John Henryism and Hypertension Risk in Blacks
|
View
|
| NCT00005171 |
|
Cardiovascular Risk Factors in United States Adolescents and Adults
|
View
|
| NCT00005170 |
|
Ambulatory Blood Pressure and Behavior
|
View
|
| NCT00005169 |
|
Lifestyle and Chronic Disease in College Alumni Harvard Alumni Health Study
|
View
|
| NCT00005168 |
|
Hyperapo B and Coronary Heart Disease
|
View
|
| NCT00005167 |
|
Diet Modification and Blood Pressure in Young People
|
View
|
| NCT00005166 |
|
Sodium Transport Genetics and Hypertension
|
View
|
| NCT00005165 |
|
Charleston Heart Study - Predictors of Coronary Disease in Blacks
|
View
|
| NCT00005164 |
|
Insulin Resistance and Blood Pressure Regulation in Blacks
|
View
|
| NCT00005163 |
|
Validation and Field Test for Risk Appraisal Instruments
|
View
|
| NCT00005162 |
|
Epidemiology of Decline in Heart Disease Mortality
|
View
|
| NCT00005161 |
|
Longitudinal Twin Study - Cohort Study of Blood Pressure
|
View
|
| NCT00005160 |
|
Epidemiology of Cardiovascular Risk Factors in Women Healthy Women Study
|
View
|
| NCT00005159 |
|
National Longitudinal Mortality Study NLMS
|
View
|
| NCT00005158 |
|
SegregationLinkage Analysis for Hypertension
|
View
|
| NCT00005157 |
|
Speech Characteristics in Coronary Heart Disease
|
View
|
| NCT00005156 |
|
Mortality Surveillance of MRFIT Screenees
|
View
|
| NCT00005155 |
|
Physiological and Psychosocial Correlates of Type A Behavior
|
View
|
| NCT00005154 |
|
National Health and Nutrition Examination Survey IV NHANES IV
|
View
|
| NCT00005153 |
|
Etiologic Risk Factors of Cardiovascular Malformations
|
View
|
| NCT00005152 |
|
Nurses Health Study Cardiovascular Component
|
View
|
| NCT00005151 |
|
Pawtucket Heart Health Program
|
View
|
| NCT00005150 |
|
Minnesota Heart Health Program
|
View
|
| NCT00005149 |
|
Genetic and Environmental Determinants of Hypertension
|
View
|
| NCT00005148 |
|
Coronary Heart Disease Incidence Mortality and Risk Factor Relationships
|
View
|
| NCT00005147 |
|
Epidemiology of Atherosclerosis
|
View
|
| NCT00005146 |
|
Diabetes and Cardiovascular Risk In Mexico City San Antonio Heart Study
|
View
|
| NCT00005145 |
|
Minnesota Heart Survey - Risk Factor Survey
|
View
|
| NCT00005144 |
|
Coronary-Prone Behavior and Cardiovascular Reactivity
|
View
|
| NCT00005143 |
|
Stanford Five-City Multifactor Risk Reduction Study
|
View
|
| NCT00005142 |
|
Etiology and Prevalence of Peripheral Arterial Disease
|
View
|
| NCT00005141 |
|
Minneapolis Childrens Blood Pressure Study
|
View
|
| NCT00005140 |
|
Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago
|
View
|
| NCT00005139 |
|
Characterization Of Coronary Prone Pedigrees
|
View
|
| NCT00005138 |
|
High Blood Pressure in the Young
|
View
|
| NCT00005137 |
|
Heritage Study--Genetics Exercise and Risk Factors
|
View
|
| NCT00005136 |
|
Family Heart Study FHS
|
View
|
| NCT00005135 |
|
Insulin Resistance Atherosclerosis Study IRAS
|
View
|
| NCT00005134 |
|
Strong Heart Study
|
View
|
| NCT00005133 |
|
Cardiovascular Health Study CHS
|
View
|
| NCT00005132 |
|
National Growth and Health Study NGHS
|
View
|
| NCT00005131 |
|
Atherosclerosis Risk in Communities ARIC
|
View
|
| NCT00005130 |
|
Coronary Artery Risk Development in Young Adults
|
View
|
| NCT00005129 |
|
Bogalusa Heart Study
|
View
|
| NCT00005128 |
|
Lipid Research Clinics Population Studies
|
View
|
| NCT00005127 |
|
Muscatine Heart Study
|
View
|
| NCT00005126 |
|
Vietnam Era Twin VET Registry
|
View
|
| NCT00005125 |
|
NAS-NRC Twin Registry
|
View
|
| NCT00005124 |
|
National Heart Lung and Blood Institute Twin Study
|
View
|
| NCT00005123 |
|
Honolulu Heart Program
|
View
|
| NCT00005122 |
|
Evans County Studies
|
View
|
| NCT00005121 |
|
Framingham Heart Study
|
View
|
| NCT00005120 |
|
The Safety and Effectiveness of -Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
|
View
|
| NCT00005119 |
|
Altered Calcium and Vitamin D in PMDD or Severe PMS
|
View
|
| NCT00005118 |
|
The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment
|
View
|
| NCT00005117 |
|
Effect of Pravastatin on Endothelial Dysfunction Following a Single High Fat Meal
|
View
|
| NCT00005116 |
|
Depression In Juvenile Diabetics
|
View
|
| NCT00005113 |
|
A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
|
View
|
| NCT00005112 |
|
Growth Hormone Use in Cystic Fibrosis - a Multicenter Study
|
View
|
| NCT00005111 |
|
PET Scans in Normal Volunteers and Patients With Fabry Disease
|
View
|
| NCT00005110 |
|
A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis
|
View
|
| NCT00005108 |
|
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
|
View
|
| NCT00005107 |
|
Role of Nitric Oxide in Cirrhosis Relationship With Systemic Hemodynamics Renal Function Vasoactive Systems and Endotoxemia
|
View
|
| NCT00005106 |
|
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients
|
View
|
| NCT00005105 |
|
Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation
|
View
|
| NCT00005104 |
|
Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
|
View
|
| NCT00005103 |
|
Study of the Pathogenesis of Porphyria Cutanea Tarda
|
View
|
| NCT00005102 |
|
Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
|
View
|
| NCT00005101 |
|
Study of Low Bone Mass in Premenopausal or Perimenopausal Women
|
View
|
| NCT00005100 |
|
Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
|
View
|
| NCT00005098 |
|
Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
|
View
|
| NCT00005097 |
|
Green Tea Extract in Treating Patients With Actinic Keratosis
|
View
|
| NCT00005096 |
|
Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
|
View
|
| NCT00005095 |
|
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
|
View
|
| NCT00005094 |
|
Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
|
View
|
| NCT00005093 |
|
Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer
|
View
|
| NCT00005092 |
|
Chemotherapy Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
|
View
|
| NCT00005091 |
|
DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
|
View
|
| NCT00005090 |
|
S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkins Disease
|
View
|
| NCT00005089 |
|
S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkins Lymphoma
|
View
|
| NCT00005088 |
|
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
|
View
|
| NCT00005087 |
|
Paclitaxel Cisplatin and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
|
View
|
| NCT00005086 |
|
Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
|
View
|
| NCT00005085 |
|
Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
|
View
|
| NCT00005084 |
|
Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma
|
View
|
| NCT00005083 |
|
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
|
View
|
| NCT00005082 |
|
Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma
|
View
|
| NCT00005081 |
|
Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
|
View
|
| NCT00005080 |
|
506U78 in Treating Patients With Lymphoma
|
View
|
| NCT00005079 |
|
Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I Stage II or Stage III Breast Cancer
|
View
|
| NCT00005078 |
|
Tirapazamine Carboplatin and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors
|
View
|
| NCT00005077 |
|
Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction
|
View
|
| NCT00005076 |
|
Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer
|
View
|
| NCT00005075 |
|
Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer
|
View
|
| NCT00005074 |
|
Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma
|
View
|
| NCT00005073 |
|
Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
|
View
|
| NCT00005072 |
|
Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer
|
View
|
| NCT00005071 |
|
Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
|
View
|
| NCT00005070 |
|
Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer
|
View
|
| NCT00005069 |
|
Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer
|
View
|
| NCT00005068 |
|
Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors
|
View
|
| NCT00005067 |
|
Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer
|
View
|
| NCT00005066 |
|
O6-benzylguanine and Carmustine in Treating Patients With Recurrent Metastatic or Locally Advanced Soft Tissue Sarcoma
|
View
|
| NCT00005065 |
|
Chemotherapy Radiation Therapy and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
|
View
|
| NCT00005064 |
|
PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia in Blast Phase or Myelodysplastic Syndrome
|
View
|
| NCT00005062 |
|
Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
|
View
|
| NCT00005061 |
|
Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors
|
View
|
| NCT00005060 |
|
Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
|
View
|
| NCT00005059 |
|
Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer
|
View
|
| NCT00005058 |
|
Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer
|
View
|
| NCT00005057 |
|
Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma
|
View
|
| NCT00005056 |
|
Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
|
View
|
| NCT00005055 |
|
Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer
|
View
|
| NCT00005054 |
|
Temozolomide in Treating Women With Advanced Breast Cancer
|
View
|
| NCT00005053 |
|
Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
|
View
|
| NCT00005052 |
|
Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
|
View
|
| NCT00005051 |
|
Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer
|
View
|
| NCT00005050 |
|
Eniluracil Fluorouracil and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer
|
View
|
| NCT00005049 |
|
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
|
View
|
| NCT00005048 |
|
Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
|
View
|
| NCT00005047 |
|
4B951 Combination Chemotherapy in Treating Patients With Bladder Cancer
|
View
|
| NCT00005046 |
|
Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
|
View
|
| NCT00005045 |
|
Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
|
View
|
| NCT00005044 |
|
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
|
View
|
| NCT00005042 |
|
SU5416 in Treating Patients With AIDS-Related Kaposis Sarcoma
|
View
|
| NCT00005041 |
|
R115777 in Treating Patients With Relapsed Small Cell Lung Cancer
|
View
|
| NCT00005040 |
|
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkins Lymphoma
|
View
|
| NCT00005039 |
|
Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate Prostate Cancer
|
View
|
| NCT00005038 |
|
Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer
|
View
|
| NCT00005037 |
|
Temozolomide in Treating Patients With Stage IIIB Stage IV or Recurrent Non-small Cell Lung Cancer
|
View
|
| NCT00005036 |
|
Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
|
View
|
| NCT00005035 |
|
Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
|
View
|
| NCT00005033 |
|
Trastuzumab in Treating Patients With Recurrent Osteosarcoma
|
View
|
| NCT00005032 |
|
Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
|
View
|
| NCT00005031 |
|
Irofulven in Treating Patients With Persistent or Recurrent Refractory Endometrial Cancer
|
View
|
| NCT00005030 |
|
SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver
|
View
|
| NCT00005029 |
|
Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
|
View
|
| NCT00005028 |
|
Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
|
View
|
| NCT00005027 |
|
Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
|
View
|
| NCT00005026 |
|
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
|
View
|
| NCT00005025 |
|
Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer Fallopian Tube Cancer or Peritoneal Cancer
|
View
|
| NCT00005024 |
|
Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease
|
View
|
| NCT00005023 |
|
Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
|
View
|
| NCT00005022 |
|
Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
|
View
|
| NCT00005021 |
|
Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma
|
View
|
| NCT00005020 |
|
Observing Patients With Early HIV Infection
|
View
|
| NCT00005018 |
|
Safety and Effectiveness of a Combination Anti-HIV Drug Treatment
|
View
|
| NCT00005017 |
|
Effectiveness and Safety of EpivirZiagenZerit 3TCABCd4T Versus EpivirZiagenSustiva 3TCABCEFV Versus EpivirZiagenAgeneraseNorvir 3TCABCAPVRTV in HIV Patients Who Have Never Received Treatment
|
View
|
| NCT00005016 |
|
Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of Holopresencephaly
|
View
|
| NCT00005015 |
|
Treatment of Depression in Youth With Bipolar Disorders
|
View
|
| NCT00005014 |
|
Treatment of Autism in Children and Adolescents
|
View
|
| NCT00005013 |
|
Treatment of Major Depression With St Johns Wort Hypericum
|
View
|
| NCT00005012 |
|
Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
|
View
|
| NCT00005011 |
|
Combined Hormone Replacement in Menstrually-Related Mood Disorders
|
View
|
| NCT00005010 |
|
Prevention of Kidney Transplant Rejection
|
View
|
| NCT00005009 |
|
Evaluation of the Safety of Varivax in Pediatric Renal Transplant Recipients
|
View
|
| NCT00005007 |
|
Etanercept for Wegeners Granulomatosis
|
View
|
| NCT00005006 |
|
Parathyroid Hormone PTH With Alendronate for Osteoporosis
|
View
|
| NCT00005005 |
|
PaTH Study Parathyroid Hormone and Alendronate for Osteoporosis
|
View
|
| NCT00005004 |
|
Brain Processing of Language Meanings
|
View
|
| NCT00005003 |
|
Genetic Component of Handedness
|
View
|
| NCT00005002 |
|
Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine Remune
|
View
|
| NCT00005001 |
|
Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine Remune
|
View
|
| NCT00005000 |
|
Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
|
View
|
| NCT00004999 |
|
Effectiveness of a New Anti-HIV Drug AG1549 Plus Viracept Nelfinavir Plus Combivir ZidovudineLamivudine in HIV-Infected Patients
|
View
|
| NCT00004998 |
|
Safety and Effectiveness of a New Anti-HIV Drug AG1549 in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
|
View
|
| NCT00004997 |
|
Leucovorin for the Treatment of 5 q Minus Syndrome
|
View
|
| NCT00004996 |
|
Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections
|
View
|
| NCT00004994 |
|
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
|
View
|
| NCT00004993 |
|
Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis
|
View
|
| NCT00004992 |
|
Diabetes Prevention Program
|
View
|
| NCT00004991 |
|
Study of Brain Activity During Speech Production and Speech Perception
|
View
|
| NCT00004990 |
|
Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis
|
View
|
| NCT00004988 |
|
Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria
|
View
|
| NCT00004987 |
|
Treatment of Advanced AIDS Patients With Dextrin Sulfate
|
View
|
| NCT00004986 |
|
Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
|
View
|
| NCT00004985 |
|
Combination Treatment Using Capravirine AG1549 Nelfinavir and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy
|
View
|
| NCT00004984 |
|
The Diabetes Prevention Trial of Type 1 Diabetes DPT-1
|
View
|
| NCT00004983 |
|
Education and Group Support for Diabetic Hispanics
|
View
|
| NCT00004982 |
|
Combination Iron Chelation Therapy
|
View
|
| NCT00004981 |
|
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill Trizivir
|
View
|
| NCT00004980 |
|
Repetitive Transcranial Magnetic Stimulation for Voices
|
View
|
| NCT00004979 |
|
Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors
|
View
|
| NCT00004978 |
|
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
|
View
|
